Skip to content

Clinical trials

Melanoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: China Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20122
20134
20142
20156
20167
20176
20188
20198
202013
202116
202219
202320
202411
202519
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status57
Recruiting46
Completed27
Active, not recruiting11
Terminated7
Not yet recruiting6
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Cancer Hospital & Institute19
Shanghai Junshi Bioscience Co., Ltd.7
Novartis Pharmaceuticals5
Xijing Hospital5
Bristol-Myers Squibb4
Fudan University4
Shanghai Kechow Pharma, Inc.4
Sun Yat-sen University4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
BGI, China3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma157
Carcinoma, Non-Small-Cell Lung31
Lung Neoplasms20
Breast Neoplasms17
Colorectal Neoplasms17
Ovarian Neoplasms14
Carcinoma, Renal Cell12
Carcinoma, Hepatocellular11
Pancreatic Neoplasms11
Head and Neck Neoplasms10

Trials

Showing 1 to 25 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.